Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Novel antibiotics targeting bacterial cell wall biosynthesis synthesized by Incara

Sep. 8, 1999

Pyrimidine derivatives from Tularik useful for CMV infections

Sep. 8, 1999

Oxazolidinones with broad-spectrum activity claimed by Bayer

Sep. 7, 1999

Orally active nucleoside prodrugs for HBV and HIV infections designed at Medivir

Sep. 7, 1999

Novel antimycotic NND-502 assessed in systemic and lung infection models

Sep. 7, 1999

GPC and Novalon collaboration for discovery of broad-spectrum antibiotics

Sep. 7, 1999

New 4-pyrrolidinylthio carbapenem with balanced spectrum chosen for further studies

Sep. 6, 1999

Potential new penciclovir prodrug developed at SK Chemicals proves effective and safe

Sep. 6, 1999

FDA approves 50-mg vial of Abelcet for severe fungal infections

Sep. 3, 1999

Cubist continues to target bacterial enzymes for development of novel antibiotics

Sep. 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...